RecruitingNCT06417710

Standardized Clinical Assessment of Patients With Leptomeningeal Metastasis

Sponsor

University of Zurich

Enrollment

200 participants

Start Date

Jan 30, 2022

Study Type

OBSERVATIONAL

Conditions

Leptomeningeal Disease Leptomeningeal Metastasis Leptomeningeal Neoplasms Leptomeningeal Cancer

Summary

The goal of this project is to develop and validate a reproducible scorecard for the neurological assessment of patients with leptomeningeal metastases that can be used in clinical trials including such patients, as well as in clinical practice.

Eligibility

Min Age: 18 Years

Inclusion Criteria7

Adult patients (18 years or more), female or male
Histologically confirmed diagnosis of extra-CNS primary solid cancer
Diagnosis of leptomeningeal metastases confirmed or probable per EANO ESMO criteria
Performance status compatible with enrolment into clinical trials
Ability to consent
Signed informed consent form from patient
Participation in a parallel clinical trial is allowed in this non-interventional study

Exclusion Criteria3

Inability to give informed consent
Inability to adhere to recommended follow-up according to the treating physician
Vulnerable participants will not be included.

Interested in this trial?

Get notified about updates and connect with the research team.